Growth Metrics

iSpecimen (ISPC) Net Cash Flow (2020 - 2025)

iSpecimen has reported Net Cash Flow over the past 6 years, most recently at $4.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 3138.2% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $5.0 million, up 1175.53%, while the annual FY2025 figure was $5.0 million, 1175.19% up from the prior year.
  • Net Cash Flow for Q4 2025 was $4.1 million at iSpecimen, up from $2.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $17.9 million in Q4 2021 and troughed at -$11.5 million in Q1 2023.
  • A 5-year average of -$500666.8 and a median of -$388645.5 in 2023 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 6967.86% in 2021 and fell as far as 888.48% in 2021.
  • Year by year, Net Cash Flow stood at $17.9 million in 2021, then plummeted by 129.8% to -$5.3 million in 2022, then skyrocketed by 92.94% to -$377902.0 in 2023, then skyrocketed by 133.49% to $126554.0 in 2024, then surged by 3138.2% to $4.1 million in 2025.
  • Business Quant data shows Net Cash Flow for ISPC at $4.1 million in Q4 2025, $2.2 million in Q3 2025, and -$192234.0 in Q2 2025.